Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Duncan Whitaker has worked on the following 3 EPO patent applications which have been published in the last five years:

EP13187404

Vaccine

IPC classification:
A61K 39/116, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Duncan Whitaker, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12712664

PROCESS FOR PRODUCING AN IMMUNOGENIC COMPOSITION CONTAINING TETANUS TOXOID

IPC classification:
A61K 39/08, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Duncan Whitaker, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14750176

COMBINATION IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/00, A61K 39/02, A61K 39/10, A61K 39/155
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature